Media Innovation
Our strategy focused on driving both efficiency and volume for Prostate Cancer UK’s Risk Checker. Our first major change was to run digital Risk Checker activity as always on across paid search and paid social, supported with bursts of TV activity.
Our search strategy across both Google and Microsoft combined brand and generic PPC to capture both high intent users familiar with the charity and broader audiences searching for information about the disease.
As Prostate Cancer UK was placed in the ‘healthcare’ category on Meta, which is deemed to be sensitive, we were met with the challenge that we could not optimise towards conversions on this channel. To get around this, we tested a link click strategy and found that there was little-to-no impact on the volume of risks checks we delivered so we knew we could continue with this strategy throughout the rest of the year. To expand reach efficiently, we used geographical targeting on Meta. To reach those men at higher risk of developing the disease, we used census data at postcode level to target areas with a higher penetration of Black Men over the age of 45 as well as those areas determined to have higher health inequality.
We aligned all our TV activity with sport to ensure that we were speaking to men while they were engaged with the media. We ran across a range of sports including football, darts, cricket, boxing, rugby and Formula 1 to reach a breadth of men. We also monitored the news for relevant breaking stories in the sports world that would drive interest in men checking their risk of the disease. Two notable events were cyclist Sir Chris Hoy’s prostate cancer diagnosis and Formula 1’s Eddie Jordan’s sad death from the disease. We made sure that Prostate Cancer UK was present in these moments when more men would be looking for information by uncapping search and social budgets. We also secured spots on Sky News and around the Formula 1 coverage the weekend after Eddie Jordan’s death as we knew that commentary was likely to discuss the F1 legend.